Your browser doesn't support javascript.
loading
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
Parisi, Alessandro; Porzio, Giampiero; Cannita, Katia; Venditti, Olga; Avallone, Antonio; Filippi, Roberto; Salvatore, Lisa; Tortora, Giampaolo; Ribelli, Marta; Nigro, Olga; Gelsomino, Fabio; Spallanzani, Andrea; Zurlo, Valeria; Leo, Silvana; Dell'Aquila, Emanuela; Claudia, Fulgenzi; Lombardi, Pasquale; Keränen, Susana Roselló; Aimar, Giacomo; Depetris, Ilaria; Giampieri, Riccardo; Morelli, Cristina; De Tursi, Michele; Tinari, Nicola; Di Pietro, Francesca Romana; De Galitiis, Federica; Zanaletti, Nicoletta; Troiani, Teresa; Vitale, Pasquale; Garajova, Ingrid; Ghidini, Michele; Spinelli, Gian Paolo; Zoratto, Federica; Roberto, Michela; Ierino, Debora; Petrillo, Angelica; D'Orazio, Carla; Ficorella, Corrado; Cortellini, Alessio.
Affiliation
  • Parisi A; Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy. Electronic address: alexparis@hotmail.it.
  • Porzio G; Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Cannita K; Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
  • Venditti O; Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.
  • Avallone A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G.Pascale, Napoli, Italy.
  • Filippi R; Department of Oncology, University of Turin, Italy; Medical Oncology 1, Città della Salute e della Scienza di Torino, Italy.
  • Salvatore L; Università Cattolica del Sacro Cuore, Rome, Italy; Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Tortora G; Università Cattolica del Sacro Cuore, Rome, Italy; Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Ribelli M; Università Cattolica del Sacro Cuore, Rome, Italy; Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Nigro O; Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
  • Gelsomino F; Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy.
  • Spallanzani A; Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy.
  • Zurlo V; Medical Oncology, "Vito Fazzi" Hospital, Lecce, Italy.
  • Leo S; Medical Oncology, "Vito Fazzi" Hospital, Lecce, Italy.
  • Dell'Aquila E; Medical Oncology, Campus Bio-Medico, University of Rome, Rome, Italy.
  • Claudia F; Medical Oncology, Campus Bio-Medico, University of Rome, Rome, Italy.
  • Lombardi P; Department of Oncology, University of Turin, Italy.
  • Keränen SR; Department of Medical Oncology. Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Aimar G; Department of Oncology, University of Turin, Italy; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo (TO), Italy.
  • Depetris I; Medical Oncology, ASL TO4, Ospedale Civile di Ivrea, Ivrea, Turin, Italy.
  • Giampieri R; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, AOU Ospedali Riuniti-Ancona, Italy.
  • Morelli C; Medical Oncology Unit and PhD program in Systems and Experimental Medicine (XXXV cycle), Tor Vergata University Hospital, Rome, Italy.
  • De Tursi M; Department of Medical, Oral and Biotechnological Sciences, Center for Advance Studies and Technology (CAST), G. D'Annunzio University, Chieti, Italy; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
  • Tinari N; Department of Medical, Oral and Biotechnological Sciences, Center for Advance Studies and Technology (CAST), G. D'Annunzio University, Chieti, Italy; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
  • Di Pietro FR; IRCCS Istituto Dermopatico dell'Immacolata (IDI), Rome, Italy.
  • De Galitiis F; IRCCS Istituto Dermopatico dell'Immacolata (IDI), Rome, Italy.
  • Zanaletti N; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G.Pascale, Napoli, Italy.
  • Troiani T; Department of Precision Medicine, Università della Campania "Luigi Vanvitelli", Napoli, Italy.
  • Vitale P; Department of Precision Medicine, Università della Campania "Luigi Vanvitelli", Napoli, Italy.
  • Garajova I; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Ghidini M; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano.
  • Spinelli GP; UOC Territorial Oncology - AUSL Latina-CdS Aprilia, University of Rome "Sapienza", Italy.
  • Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Roberto M; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant'Andrea Hospital, Rome, Italy.
  • Ierino D; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Oncology Unit, Sant'Andrea Hospital, Rome, Italy.
  • Petrillo A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy.
  • D'Orazio C; Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Ficorella C; Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Cortellini A; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Clin Colorectal Cancer ; 20(4): 318-325, 2021 12.
Article in En | MEDLINE | ID: mdl-34380594
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins B-raf Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Colorectal Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Proto-Oncogene Proteins B-raf Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Colorectal Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2021 Document type: Article Country of publication: Estados Unidos